Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
NCT07105163 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 480
Last updated 2025-08-05
Summary
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.
Conditions
- Post Menopausal Osteoporosis
Sponsors & Collaborators
-
Procare Health Iberia S.L.
lead INDUSTRY
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-03
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
NCT00578981 ·Status: COMPLETED ·Phase: NA
-
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
NCT00936260 ·Status: COMPLETED ·Phase: NA
-
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
NCT02732210 ·Status: COMPLETED
-
Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
NCT02090400 ·Status: COMPLETED ·Phase: PHASE4
-
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence to PTH(1-84) Treatment (FP-002-IM)
NCT00478569 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates
NCT00936897 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
NCT04757376 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
NCT01753856 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
NCT00778154 ·Status: COMPLETED
-
Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
NCT02472782 ·Status: COMPLETED
-
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
NCT01657162 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women
NCT00540878 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
NCT01732770 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
NCT01631214 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis
NCT01668589 ·Status: COMPLETED
-
Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates
NCT02575157 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
NCT00577421 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
NCT02166437 ·Status: UNKNOWN
-
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
NCT05347082 ·Status: COMPLETED ·Phase: NA
-
Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors
NCT02616744 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Teriparatide in Severe Osteoporosis
NCT00696644 ·Status: COMPLETED
-
A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
NCT00100555 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of AK159 in Healthy Postmenopausal Women
NCT01551602 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
NCT05372224 ·Status: COMPLETED ·Phase: NA